Thank you for your presentation, Mr. Gagnon.
I was struck by this right from the outset: purchases of prescription drugs are about the same in Canada and in the U.K., but the U.K. has twice as many residents as Canada. I read your article, and there seems to be a faulty perception of the provisions of the legal framework in Canada, almost as if that framework was a hostile environment for the pharmaceutical industry. I would like you to tell us about that perception, which differs from the studies proving that our approval system is not that slow and ineffective.